# Rocket Pharmaceuticals, Inc.: Form 8-K, filed Aug 10, 2026

- Company: [Rocket Pharmaceuticals, Inc.](/companies/rckt.md) (CIK 1281895)
- Form: 8-K
- Filed: 2026-08-10
- Accepted by EDGAR: Aug 10, 2026, 16:17 ET
- Period: 2026-08-10
- Accession: 0001140361-26-032028
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1281895/000114036126032028/ef20079821_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1281895/000114036126032028/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1281895/000114036126032028/ef20079821_8k.htm

Filed Aug 10, 2026.
Source: SEC EDGAR, the filing index for accession 0001140361-26-032028. Last ingested by Listed: Nov 13, 2026, 17:09 ET. No prices; not investment advice.